{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:24:07Z","timestamp":1791901447716,"version":"4.3.4"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-65596-0","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T12:28:42Z","timestamp":1764160122000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Orphan broadly RBD-binding antibodies annotate three remaining conserved RBD epitopes along SARS-CoV-2 evolution"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0108-9556","authenticated-orcid":false,"given":"Minxiang","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinong","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0347-9104","authenticated-orcid":false,"given":"Xiaoyu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanchen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingsong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaying","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luotian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyuan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzhen","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiyu","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2654-0879","authenticated-orcid":false,"given":"Thiago Y.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2095-2151","authenticated-orcid":false,"given":"Zijun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunjiao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anqi","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Zai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0256-9650","authenticated-orcid":false,"given":"Christian T.","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2416-7708","authenticated-orcid":false,"given":"Youhua","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8283-7135","authenticated-orcid":false,"given":"Shibo","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2255-0391","authenticated-orcid":false,"given":"Lu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2795-4740","authenticated-orcid":false,"given":"Rong","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1039-3752","authenticated-orcid":false,"given":"Fan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8741-0202","authenticated-orcid":false,"given":"Lei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2454-7652","authenticated-orcid":false,"given":"Pengfei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2855-9837","authenticated-orcid":false,"given":"Hin","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6416-1733","authenticated-orcid":false,"given":"Qiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,26]]},"reference":[{"key":"65596_CR1","first-page":"162","volume":"21","author":"AM Carabelli","year":"2023","unstructured":"Carabelli, A. M. et al. SARS-CoV-2 variant biology: immune escape, transmission and fitness. Nat. Rev. Microbiol 21, 162\u2013177 (2023).","journal-title":"Nat. Rev. Microbiol"},{"key":"65596_CR2","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/s41576-021-00408-x","volume":"22","author":"K Tao","year":"2021","unstructured":"Tao, K. et al. The biological and clinical significance of emerging SARS-CoV-2 variants. Nat. Rev. Genet 22, 757\u2013773 (2021).","journal-title":"Nat. Rev. Genet"},{"key":"65596_CR3","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1038\/s41564-023-01504-w","volume":"8","author":"C Roemer","year":"2023","unstructured":"Roemer, C. et al. SARS-CoV-2 evolution in the Omicron era. Nat. Microbiol 8, 1952\u20131959 (2023).","journal-title":"Nat. Microbiol"},{"key":"65596_CR4","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/s41392-022-01105-9","volume":"7","author":"S Xia","year":"2022","unstructured":"Xia, S., Wang, L., Zhu, Y., Lu, L. & Jiang, S. Origin, virological features, immune evasion and intervention of SARS-CoV-2 Omicron sublineages. Signal Transduct. Target Ther. 7, 241 (2022).","journal-title":"Signal Transduct. Target Ther."},{"key":"65596_CR5","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/s41586-021-03944-y","volume":"599","author":"P Mlcochova","year":"2021","unstructured":"Mlcochova, P. et al. SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion. Nature 599, 114\u2013119 (2021).","journal-title":"Nature"},{"key":"65596_CR6","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.1016\/j.cell.2021.03.055","volume":"184","author":"W Dejnirattisai","year":"2021","unstructured":"Dejnirattisai, W. et al. Antibody evasion by the P.1 strain of SARS-CoV-2. Cell 184, 2939\u20132954.e2939 (2021).","journal-title":"Cell"},{"key":"65596_CR7","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/s41586-021-03398-2","volume":"593","author":"P Wang","year":"2021","unstructured":"Wang, P. et al. Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7. Nature 593, 130\u2013135 (2021).","journal-title":"Nature"},{"key":"65596_CR8","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/s41586-021-03720-y","volume":"596","author":"RE Chen","year":"2021","unstructured":"Chen, R. E. et al. In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains. Nature 596, 103\u2013108 (2021).","journal-title":"Nature"},{"key":"65596_CR9","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.cell.2022.12.018","volume":"186","author":"Q Wang","year":"2023","unstructured":"Wang, Q. et al. Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants. Cell 186, 279\u2013286.e278 (2023).","journal-title":"Cell"},{"key":"65596_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.100991","volume":"4","author":"Q He","year":"2023","unstructured":"He, Q. et al. An updated atlas of antibody evasion by SARS-CoV-2 Omicron sub-variants including BQ.1.1 and XBB. Cell Rep. Med. 4, 100991 (2023).","journal-title":"Cell Rep. Med"},{"key":"65596_CR11","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/s41586-021-04389-z","volume":"602","author":"D Planas","year":"2022","unstructured":"Planas, D. et al. Considerable escape of SARS-CoV-2 Omicron to antibody neutralization. Nature 602, 671\u2013675 (2022).","journal-title":"Nature"},{"key":"65596_CR12","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/s41586-022-04980-y","volume":"608","author":"Y Cao","year":"2022","unstructured":"Cao, Y. et al. BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection. Nature 608, 593\u2013602 (2022).","journal-title":"Nature"},{"key":"65596_CR13","doi-asserted-by":"publisher","first-page":"e397","DOI":"10.1016\/S1473-3099(23)00555-8","volume":"23","author":"Q Wang","year":"2023","unstructured":"Wang, Q. et al. Antibody neutralisation of emerging SARS-CoV-2 subvariants: EG.5.1 and XBC.1.6. Lancet Infect. Dis. 23, e397\u2013e398 (2023).","journal-title":"Lancet Infect. Dis."},{"key":"65596_CR14","doi-asserted-by":"publisher","unstructured":"Qu, P. et al. Immune evasion, infectivity, and fusogenicity of SARS-CoV-2 BA.2.86 and FLip variants. Cell, https:\/\/doi.org\/10.1016\/j.cell.2023.12.026 (2024).","DOI":"10.1016\/j.cell.2023.12.026"},{"key":"65596_CR15","doi-asserted-by":"crossref","unstructured":"Jian, F. et al. Evolving antibody response to SARS-CoV-2 antigenic shift from XBB to JN.1. Nature 637, 921\u2013929 (2024).","DOI":"10.1038\/s41586-024-08315-x"},{"key":"65596_CR16","first-page":"521","volume":"614","author":"Y Cao","year":"2023","unstructured":"Cao, Y. et al. Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution. Nature 614, 521\u2013529 (2023).","journal-title":"Nature"},{"key":"65596_CR17","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/s41422-023-00781-8","volume":"33","author":"B Gao","year":"2023","unstructured":"Gao, B. et al. Repeated vaccination of inactivated SARS-CoV-2 vaccine dampens neutralizing antibodies against Omicron variants in breakthrough infection. Cell Res. 33, 258\u2013261 (2023).","journal-title":"Cell Res."},{"key":"65596_CR18","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41586-023-06753-7","volume":"625","author":"A Yisimayi","year":"2024","unstructured":"Yisimayi, A. et al. Repeated Omicron exposures override ancestral SARS-CoV-2 immune imprinting. Nature 625, 148\u2013156 (2024).","journal-title":"Nature"},{"key":"65596_CR19","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1126\/science.abo7896","volume":"377","author":"TN Starr","year":"2022","unstructured":"Starr, T. N. et al. Shifting mutational constraints in the SARS-CoV-2 receptor-binding domain during viral evolution. Science 377, 420\u2013424 (2022).","journal-title":"Science"},{"key":"65596_CR20","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1093\/procel\/pwae007","volume":"15","author":"S Xue","year":"2024","unstructured":"Xue, S., Han, Y., Wu, F. & Wang, Q. Mutations in the SARS-CoV-2 spike receptor binding domain and their delicate balance between ACE2 affinity and antibody evasion. Protein Cell 15, 403\u2013418 (2024).","journal-title":"Protein Cell"},{"key":"65596_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.28440","volume":"95","author":"S Li","year":"2023","unstructured":"Li, S. et al. Characterization of cross-reactive monoclonal antibodies against SARS-CoV-1 and SARS-CoV-2: Implication for rational design and development of pan-sarbecovirus vaccines and neutralizing antibodies. J. Med Virol. 95, e28440 (2023).","journal-title":"J. Med Virol."},{"key":"65596_CR22","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1007\/s11684-022-0981-7","volume":"17","author":"G Lu","year":"2023","unstructured":"Lu, G. et al. Primary assessment of the diversity of Omicron sublineages and the epidemiologic features of autumn\/winter 2022 COVID-19 wave in Chinese mainland. Front Med. 17, 758\u2013767 (2023).","journal-title":"Front Med."},{"key":"65596_CR23","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1056\/NEJMoa2202261","volume":"386","author":"L Dai","year":"2022","unstructured":"Dai, L. et al. Efficacy and Safety of the RBD-Dimer-Based Covid-19 Vaccine ZF2001 in Adults. N. Engl. J. Med. 386, 2097\u20132111 (2022).","journal-title":"N. Engl. J. Med."},{"key":"65596_CR24","doi-asserted-by":"publisher","unstructured":"Yang, S. et al. Fast evolution of SARS-CoV-2 BA.2\u00b786 to JN.1 under heavy immune pressure. Lancet Infect Dis. https:\/\/doi.org\/10.1016\/S1473-3099(23)00744-2 (2023).","DOI":"10.1016\/S1473-3099(23)00744-2"},{"key":"65596_CR25","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/S1473-3099(23)00278-5","volume":"23","author":"D Yamasoba","year":"2023","unstructured":"Yamasoba, D. et al. Virological characteristics of the SARS-CoV-2 omicron XBB.1.16 variant. Lancet Infect. Dis. 23, 655\u2013656 (2023).","journal-title":"Lancet Infect. Dis."},{"key":"65596_CR26","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/s41586-023-06750-w","volume":"624","author":"Q Wang","year":"2023","unstructured":"Wang, Q. et al. Antigenicity and receptor affinity of SARS-CoV-2 BA.2.86 spike. Nature 624, 639\u2013644 (2023).","journal-title":"Nature"},{"key":"65596_CR27","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41421-022-00468-1","volume":"8","author":"Y Ling","year":"2022","unstructured":"Ling, Y. et al. The Omicron BA.2.2.1 subvariant drove the wave of SARS-CoV-2 outbreak in Shanghai during spring 2022. Cell Discov. 8, 97 (2022).","journal-title":"Cell Discov."},{"key":"65596_CR28","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1016\/S0140-6736(22)00838-8","volume":"399","author":"X Zhang","year":"2022","unstructured":"Zhang, X., Zhang, W. & Chen, S. Shanghai\u2019s life-saving efforts against the current omicron wave of the COVID-19 pandemic. Lancet 399, 2011\u20132012 (2022).","journal-title":"Lancet"},{"key":"65596_CR29","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1038\/s41586-022-04466-x","volume":"603","author":"K Wang","year":"2022","unstructured":"Wang, K. et al. Memory B cell repertoire from triple vaccinees against diverse SARS-CoV-2 variants. Nature 603, 919\u2013925 (2022).","journal-title":"Nature"},{"key":"65596_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.108699","volume":"34","author":"Y Zhou","year":"2021","unstructured":"Zhou, Y. et al. Enhancement versus neutralization by SARS-CoV-2 antibodies from a convalescent donor associates with distinct epitopes on the RBD. Cell Rep. 34, 108699 (2021).","journal-title":"Cell Rep."},{"key":"65596_CR31","doi-asserted-by":"crossref","unstructured":"Wang, K. et al. A third dose of inactivated vaccine augments the potency, breadth, and duration of anamnestic responses against SARS-CoV-2. medRxiv, 2021.2009.2002.21261735 (2021).","DOI":"10.1101\/2021.09.02.21261735"},{"key":"65596_CR32","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41586-022-04778-y","volume":"607","author":"F Muecksch","year":"2022","unstructured":"Muecksch, F. et al. Increased memory B cell potency and breadth after a SARS-CoV-2 mRNA boost. Nature 607, 128\u2013134 (2022).","journal-title":"Nature"},{"key":"65596_CR33","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/s41586-021-03324-6","volume":"592","author":"Z Wang","year":"2021","unstructured":"Wang, Z. et al. mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants. Nature 592, 616\u2013622 (2021).","journal-title":"Nature"},{"key":"65596_CR34","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/s41586-020-2456-9","volume":"584","author":"DF Robbiani","year":"2020","unstructured":"Robbiani, D. F. et al. Convergent antibody responses to SARS-CoV-2 in convalescent individuals. Nature 584, 437\u2013442 (2020).","journal-title":"Nature"},{"key":"65596_CR35","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/s41586-021-03696-9","volume":"595","author":"Z Wang","year":"2021","unstructured":"Wang, Z. et al. Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection. Nature 595, 426\u2013431 (2021).","journal-title":"Nature"},{"key":"65596_CR36","doi-asserted-by":"publisher","unstructured":"Jia, Z. et al. A third dose of inactivated vaccine augments the potency, breadth, and duration of anamnestic responses against SARS-CoV-2. Protein Cell, https:\/\/doi.org\/10.1093\/procel\/pwae033 (2024).","DOI":"10.1093\/procel\/pwae033"},{"key":"65596_CR37","doi-asserted-by":"publisher","first-page":"e457","DOI":"10.1016\/S1473-3099(23)00573-X","volume":"23","author":"S Yang","year":"2023","unstructured":"Yang, S. et al. Antigenicity and infectivity characterisation of SARS-CoV-2 BA.2.86. Lancet Infect. Dis. 23, e457\u2013e459 (2023).","journal-title":"Lancet Infect. Dis."},{"key":"65596_CR38","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/s41392-023-01495-4","volume":"8","author":"J Yang","year":"2023","unstructured":"Yang, J. et al. Low levels of neutralizing antibodies against XBB Omicron subvariants after BA.5 infection. Signal Transduct. Target Ther. 8, 252 (2023).","journal-title":"Signal Transduct. Target Ther."},{"key":"65596_CR39","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/s41586-020-2349-y","volume":"583","author":"D Pinto","year":"2020","unstructured":"Pinto, D. et al. Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody. Nature 583, 290\u2013295 (2020).","journal-title":"Nature"},{"key":"65596_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111845","volume":"41","author":"Y Cao","year":"2022","unstructured":"Cao, Y. et al. Rational identification of potent and broad sarbecovirus-neutralizing antibody cocktails from SARS convalescents. Cell Rep. 41, 111845 (2022).","journal-title":"Cell Rep."},{"key":"65596_CR41","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2205784119","volume":"119","author":"M Yuan","year":"2022","unstructured":"Yuan, M. et al. A broad and potent neutralization epitope in SARS-related coronaviruses. Proc. Natl Acad. Sci. USA 119, e2205784119 (2022).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"65596_CR42","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1126\/science.abb7269","volume":"368","author":"M Yuan","year":"2020","unstructured":"Yuan, M. et al. A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV. Science 368, 630\u2013633 (2020).","journal-title":"Science"},{"key":"65596_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32665-7","volume":"13","author":"Z Zhao","year":"2022","unstructured":"Zhao, Z. et al. Omicron SARS-CoV-2 mutations stabilize spike up-RBD conformation and lead to a non-RBM-binding monoclonal antibody escape. Nat. Commun. 13, 4958 (2022).","journal-title":"Nat. Commun."},{"key":"65596_CR44","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.chom.2020.07.002","volume":"28","author":"J Huo","year":"2020","unstructured":"Huo, J. et al. Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike. Cell Host Microbe. 28, 497 (2020).","journal-title":"Cell Host Microbe."},{"key":"65596_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19146-5","volume":"11","author":"AG Wrobel","year":"2020","unstructured":"Wrobel, A. G. et al. Antibody-mediated disruption of the SARS-CoV-2 spike glycoprotein. Nat. Commun. 11, 5337 (2020).","journal-title":"Nat. Commun."},{"key":"65596_CR46","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/j.cell.2020.08.012","volume":"182","author":"TN Starr","year":"2020","unstructured":"Starr, T. N. et al. Deep mutational scanning of sars-cov-2 receptor binding domain reveals constraints on folding and ACE2 binding. Cell 182, 1295\u20131310.e1220 (2020).","journal-title":"Cell"},{"key":"65596_CR47","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1080\/22221751.2020.1729069","volume":"9","author":"X Tian","year":"2020","unstructured":"Tian, X. et al. Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody. Emerg. Microbes Infect. 9, 382\u2013385 (2020).","journal-title":"Emerg. Microbes Infect."},{"key":"65596_CR48","doi-asserted-by":"publisher","first-page":"4908","DOI":"10.4049\/jimmunol.174.8.4908","volume":"174","author":"Y He","year":"2005","unstructured":"He, Y., Lu, H., Siddiqui, P., Zhou, Y. & Jiang, S. Receptor-binding domain of severe acute respiratory syndrome coronavirus spike protein contains multiple conformation-dependent epitopes that induce highly potent neutralizing antibodies. J. Immunol. 174, 4908\u20134915 (2005).","journal-title":"J. Immunol."},{"key":"65596_CR49","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/s41392-020-00402-5","volume":"5","author":"Z Liu","year":"2020","unstructured":"Liu, Z. et al. RBD-Fc-based COVID-19 vaccine candidate induces highly potent SARS-CoV-2 neutralizing antibody response. Signal Transduct. Target Ther. 5, 282 (2020).","journal-title":"Signal Transduct. Target Ther."},{"key":"65596_CR50","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1126\/science.abh2315","volume":"374","author":"KM Hastie","year":"2021","unstructured":"Hastie, K. M. et al. Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium study. Science 374, 472\u2013478 (2021).","journal-title":"Science"},{"key":"65596_CR51","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/s41586-020-2852-1","volume":"588","author":"CO Barnes","year":"2020","unstructured":"Barnes, C. O. et al. SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies. Nature 588, 682\u2013687 (2020).","journal-title":"Nature"},{"key":"65596_CR52","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/s41590-023-01449-6","volume":"24","author":"B Ju","year":"2023","unstructured":"Ju, B. et al. Infection with wild-type SARS-CoV-2 elicits broadly neutralizing and protective antibodies against omicron subvariants. Nat. Immunol. 24, 690\u2013699 (2023).","journal-title":"Nat. Immunol."},{"key":"65596_CR53","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.ade0958","volume":"8","author":"F Bianchini","year":"2023","unstructured":"Bianchini, F. et al. Human neutralizing antibodies to cold linear epitopes and subdomain 1 of the SARS-CoV-2 spike glycoprotein. Sci. Immunol. 8, eade0958 (2023).","journal-title":"Sci. Immunol."},{"key":"65596_CR54","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.immuni.2023.02.005","volume":"56","author":"P Zhou","year":"2023","unstructured":"Zhou, P. et al. Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause deadly disease. Immunity 56, 669\u2013686.e667 (2023).","journal-title":"Immunity"},{"key":"65596_CR55","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2023.2292071","volume":"13","author":"J Cai","year":"2024","unstructured":"Cai, J. et al. Risk of reinfection and severity with the predominant BA.5 Omicron subvariant China, from December 2022 to January 2023. Emerg. Microbes Infect. 13, 2292071 (2024).","journal-title":"Emerg. Microbes Infect."},{"key":"65596_CR56","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.chom.2020.05.010","volume":"28","author":"Q Wang","year":"2020","unstructured":"Wang, Q. et al. A Combination of Human Broadly Neutralizing Antibodies against Hepatitis B Virus HBsAg with Distinct Epitopes Suppresses Escape Mutations. Cell Host Microbe. 28, 335\u2013349.e336 (2020).","journal-title":"Cell Host Microbe."},{"key":"65596_CR57","doi-asserted-by":"publisher","first-page":"W503","DOI":"10.1093\/nar\/gkn316","volume":"36","author":"X Brochet","year":"2008","unstructured":"Brochet, X., Lefranc, M. P. & Giudicelli, V. IMGT\/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis. Nucleic Acids Res. 36, W503\u2013508 (2008).","journal-title":"Nucleic Acids Res."},{"key":"65596_CR58","doi-asserted-by":"publisher","first-page":"W34","DOI":"10.1093\/nar\/gkt382","volume":"41","author":"J Ye","year":"2013","unstructured":"Ye, J., Ma, N., Madden, T. L. & Ostell, J. M. IgBLAST: an immunoglobulin variable domain sequence analysis tool. Nucleic Acids Res. 41, W34\u201340 (2013).","journal-title":"Nucleic Acids Res."},{"key":"65596_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2020.100129","volume":"1","author":"Y Zhou","year":"2020","unstructured":"Zhou, Y. et al. Single-Cell Sorting of HBsAg-Binding Memory B Cells from human peripheral blood mononuclear cells and antibody cloning. STAR Protoc. 1, 100129 (2020).","journal-title":"STAR Protoc."},{"key":"65596_CR60","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1126\/science.1207227","volume":"333","author":"JF Scheid","year":"2011","unstructured":"Scheid, J. F. et al. Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding. Science 333, 1633\u20131637 (2011).","journal-title":"Science"},{"key":"65596_CR61","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41421-024-00648-1","volume":"10","author":"X Zhao","year":"2024","unstructured":"Zhao, X. et al. Potent and broadly neutralizing antibodies against sarbecoviruses induced by sequential COVID-19 vaccination. Cell Discov. 10, 14 (2024).","journal-title":"Cell Discov."},{"key":"65596_CR62","doi-asserted-by":"publisher","first-page":"5090","DOI":"10.1002\/jmv.28017","volume":"94","author":"X Wang","year":"2022","unstructured":"Wang, X. et al. Neutralization of distinct Omicron sublineages by longitudinal vaccination sera. J. Med. Virol. 94, 5090\u20135092 (2022).","journal-title":"J. Med. Virol."},{"key":"65596_CR63","first-page":"785","volume":"609","author":"H Chu","year":"2022","unstructured":"Chu, H. et al. Coronaviruses exploit a host cysteine-aspartic protease for replication. Nature 609, 785\u2013792 (2022).","journal-title":"Nature"},{"key":"65596_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104753","volume":"95","author":"H Shuai","year":"2023","unstructured":"Shuai, H. et al. The viral fitness and intrinsic pathogenicity of dominant SARS-CoV-2 Omicron sublineages BA.1, BA.2, and BA.5. EBioMedicine 95, 104753 (2023).","journal-title":"EBioMedicine"},{"key":"65596_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104916","volume":"99","author":"B Hu","year":"2024","unstructured":"Hu, B. et al. Divergent trajectory of replication and intrinsic pathogenicity of SARS-CoV-2 Omicron post-BA.2\/5 subvariants in the upper and lower respiratory tract. EBioMedicine 99, 104916 (2024).","journal-title":"EBioMedicine"},{"key":"65596_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100743","volume":"3","author":"JF Chan","year":"2022","unstructured":"Chan, J. F. et al. Virological features and pathogenicity of SARS-CoV-2 Omicron BA.2. Cell Rep. Med. 3, 100743 (2022).","journal-title":"Cell Rep. Med."},{"key":"65596_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-53033-7","volume":"15","author":"Y Liu","year":"2024","unstructured":"Liu, Y. et al. Lineage-specific pathogenicity, immune evasion, and virological features of SARS-CoV-2 BA.2.86\/JN.1 and EG.5.1\/HK.3. Nat. Commun. 15, 8728 (2024).","journal-title":"Nat. Commun."},{"key":"65596_CR68","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.add3867","volume":"9","author":"JF Chan","year":"2023","unstructured":"Chan, J. F. et al. Altered host protease determinants for SARS-CoV-2 Omicron. Sci. Adv. 9, eadd3867 (2023).","journal-title":"Sci. Adv."},{"key":"65596_CR69","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41586-022-04442-5","volume":"603","author":"H Shuai","year":"2022","unstructured":"Shuai, H. et al. Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron. Nature 603, 693\u2013699 (2022).","journal-title":"Nature"},{"key":"65596_CR70","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/j.chom.2023.06.006","volume":"31","author":"LM Molinos-Albert","year":"2023","unstructured":"Molinos-Albert, L. M. et al. Anti-V1\/V3-glycan broadly HIV-1 neutralizing antibodies in a post-treatment controller. Cell Host Microbe 31, 1275\u20131287.e1278 (2023).","journal-title":"Cell Host Microbe"},{"key":"65596_CR71","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nmeth.4193","volume":"14","author":"SQ Zheng","year":"2017","unstructured":"Zheng, S. Q. et al. MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat. Methods 14, 331\u2013332 (2017).","journal-title":"Nat. Methods"},{"key":"65596_CR72","doi-asserted-by":"publisher","unstructured":"Zivanov, J. et al. New tools for automated high-resolution cryo-EM structure determination in RELION-3. Elife 7, https:\/\/doi.org\/10.7554\/eLife.42166 (2018).","DOI":"10.7554\/eLife.42166"},{"key":"65596_CR73","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nmeth.4169","volume":"14","author":"A Punjani","year":"2017","unstructured":"Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290\u2013296 (2017).","journal-title":"Nat. Methods"},{"key":"65596_CR74","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen, E. F. et al. UCSF Chimera-a visualization system for exploratory research and analysis. J. Comput Chem. 25, 1605\u20131612 (2004).","journal-title":"J. Comput Chem."},{"key":"65596_CR75","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1038\/s42003-021-02399-1","volume":"4","author":"R Sanchez-Garcia","year":"2021","unstructured":"Sanchez-Garcia, R. et al. DeepEMhancer: a deep learning solution for cryo-EM volume post-processing. Commun. Biol. 4, 874 (2021).","journal-title":"Commun. Biol."},{"key":"65596_CR76","doi-asserted-by":"publisher","first-page":"W296","DOI":"10.1093\/nar\/gky427","volume":"46","author":"A Waterhouse","year":"2018","unstructured":"Waterhouse, A. et al. SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res. 46, W296\u2013W303 (2018).","journal-title":"Nucleic Acids Res."},{"key":"65596_CR77","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr D. Biol. Crystallogr 66, 486\u2013501 (2010).","journal-title":"Acta Crystallogr D. Biol. Crystallogr"},{"key":"65596_CR78","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1107\/S0907444909052925","volume":"66","author":"PD Adams","year":"2010","unstructured":"Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D. Biol. Crystallogr 66, 213\u2013221 (2010).","journal-title":"Acta Crystallogr D. Biol. Crystallogr"},{"key":"65596_CR79","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/pro.3943","volume":"30","author":"EF Pettersen","year":"2021","unstructured":"Pettersen, E. F. et al. UCSF ChimeraX: Structure visualization for researchers, educators, and developers. Protein Sci. 30, 70\u201382 (2021).","journal-title":"Protein Sci."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65596-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65596-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65596-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T14:03:23Z","timestamp":1764165803000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65596-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["65596"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-65596-0","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,26]]},"assertion":[{"value":"14 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Q.W., M.X., F.W., L.S., H.C., and P.W. have a provisional patent application. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10566"}}